Nasdaq · Healthcare
ILLUMINA, INC. (ILMN)
As-reported financials and recent SEC filings for ILLUMINA, INC., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$4.34B
Net income
$850.0M
Net margin
19.6%
Diluted EPS
$5.45
ROE
31.2%
P/E (TTM)
32.0×
Market cap
$26.71B
Debt / equity
—
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2023 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $4.34B | $4.37B | $4.50B | $4.58B | $4.53B |
| Gross profit | $2.87B | $2.86B | $2.74B | $2.97B | $3.15B |
| Operating income | $807.0M | $-833.0M | $-1.07B | $-4.18B | $-123.0M |
| Net income | $850.0M | $-1.22B | $-1.16B | $-4.40B | $762.0M |
| Diluted EPS | $5.45 | $-7.69 | $-7.34 | $-28.00 | $5.04 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
1442026-06-25
View on EDGAR →1442026-06-25
View on EDGAR →42026-06-25
View on EDGAR →42026-06-23
View on EDGAR →32026-06-23
View on EDGAR →8-K2026-06-23
View on EDGAR →42026-06-09
View on EDGAR →1442026-06-05
View on EDGAR →Go deeper on ILMN
Search ILLUMINA, INC.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.